We represent U.S. and foreign issuers and underwriters in a variety of capital-raising transactions. These transactions range from initial public offerings to offerings by seasoned public companies and involve the issuances of high-yield, investment grade and convertible debt and common and preferred stock in the U.S. and foreign markets. Our extensive experience in capital markets includes registered offerings as well as Rule 144A offerings.
We participate in capital markets transactions involving issuers in numerous industries, including healthcare, communications, aerospace, insurance, reinsurance, asset management, software, manufacturing, gaming and real estate.
Our Capital Markets Group draws on the general and particular experience within our Corporate & Financial Services Department and the other departments throughout our firm to provide high quality legal services efficiently and effectively.
Experience
Representative Experience
Our representative capital markets transactions include the following offerings:
Canadian Imperial Bank of Commerce
We represented Canadian Imperial Bank of Commerce on its SEC-registered multi-tranche $2.25 billion senior notes offering. (2024)
Resideo Technologies
We represented Resideo Technologies in connection with its $600 million Rule 144A offering of senior notes. (2024)
Xerox Holdings Corporation
We represented Xerox Holdings Corporation in the concurrent offerings of $350 million of convertible senior notes and $500 million of senior notes and a related tender offer. (2024)
Marsh & McLennan
We represented the underwriters in Marsh & McLennan’s $1.6 billion senior notes offering. (2023)
SCOR/Atlas Capital DAC
We represented SCOR in connection with its $75 million catastrophe bond offering, via Irish-incorporated Atlas Capital DAC. (2023)
Take-Two Interactive Software, Inc.
We represented Take-Two Interactive Software, Inc. in its $1 billion senior notes offering. (2023)
FIS
We represented FIS in connection with its public offering of $2.5 billion of senior notes. (2022)
Take-Two Interactive Software, Inc.
We represented Take-Two Interactive Software, Inc. in its offering of $2.7 billion of Senior Notes, consisting of $1 billion of its 3.300% Senior Notes due 2024, $600 million of its 3.550% Senior Notes due 2025, $600 million of its 3.700% Senior Notes due 2027, and $500 million of its 4.000% Senior Notes due 2032. (2022)
Marsh McLennan
We represented the underwriters in Marsh McLennan’s $1 billion senior notes offering. (2022)
Marsh & McLennan Companies, Inc.
We represented the underwriters in Marsh & McLennan’s $750 million senior notes offering. (2021)
W. R. Berkley Corporation
We represented W. R. Berkley Corporation in its offering of $350 million aggregate principal amount of 3.150% Senior Notes due 2061. (2021)
AdaptHealth LLC
We represented AdaptHealth in its Rule 144A/Regulation S offering of $600 million aggregate principal amount of 5.125% Senior Notes due 2030. (2021)
HealthEquity, Inc.
We represented HealthEquity in in the offerings under Rule 144A of $600 million senior notes due 2029. (2021)
Lancashire Holdings Limited
We represented Lancashire Holdings Limited on its inaugural offering of $450 million aggregate principal amount of 5.625% Fixed-Rate Reset Junior Subordinated Notes due 2041. (2021)
W. R. Berkley Corporation
We represented W. R. Berkley Corporation in its offering of $400 million aggregate principal amount of 3.550% Senior Notes due 2052. (2021)
Interpublic Group
We represented Interpublic Group in its registered public offering of $500 million aggregate principal amount of its 2.400% Senior Notes due 2031 and $500 million aggregate principal amount of its 3.375% Senior Notes due 2041. (2021)
Club Car/Platinum Equity
We served as financing counsel to Platinum Equity in its $1.7 billion acquisition of Club Car. (2021)
The Allstate Corporation
We represented The Allstate Corporation in its offering of $1.2 billion of 5-year and 10-year senior notes through a syndicate exclusively comprised of minority-owned, women-owned and veteran-owned business enterprises (MWVBEs), marking the first time a corporate bond offering of this size has been managed exclusively by MWVBEs. (2020)
AdaptHealth LLC
We represented AdaptHealth in its Rule 144A/Regulation S offering of $500 million aggregate principal amount of 4.625% Senior Notes due 2029. (2020)
Franklin Templeton
We represented Franklin Templeton in its public offering of $750 million aggregate principal amount of 1.600% Notes due 2030. (2020)
W. R. Berkley Corporation
We represented W. R. Berkley Corporation in its offering of $250 million aggregate principal amount of 4.25% Subordinated Debentures due 2060. (2020)
W. R. Berkley Corporation
We represented W. R. Berkley Corporation in its additional $170 million offering of 4.00% Senior Notes Due 2050. (2020)
Joseph T. Ryerson & Son, Inc.
We represented Joseph T. Ryerson & Son, Inc., a Platinum Equity portfolio company, in its offering of $500 million aggregate principal amount of 8.50% Senior Secured Notes due 2028. (2020)
Herbie Re Ltd.
We advised Herbie Re Ltd. in its $125 million catastrophe bond offering. (2020)
W. R. Berkley Corporation
We represented W. R. Berkley Corporation in its $300 million offering of 4.00% Senior Notes Due 2050. (2020)
Level 3 Financing
We represented CenturyLink, Inc. in the $1.5 billion 144A offerings of Level 3 Financing, Inc. senior secured notes. (2019)
W. R. Berkley Corporation
We represented W. R. Berkley Corporation in its $300 million offering of 5.10% Subordinated Debentures Due 2059. (2019)
Fidelity National Information Services, Inc.
We represented FIS in its approximately $2.9 billion multi-tranche senior notes offering and concurrent tender offers. (2019)
Level 3 Financing
We represented CenturyLink, Inc. in the $1 billion 144A offering of Level 3 Financing, Inc. senior notes. (2019)
Clovis Oncology, Inc.
We represented Clovis Oncology in its $250 million 144A offering of 4.50% convertible senior notes due 2024. (2019)
LSB Industries, Inc.
We represented LSB Industries in the completion of its previously announced private offering of $35 million in aggregate principal amount of its 9.625% Senior Secured Notes due 2023. The Notes constitute a further issuance of the 9.625% Senior Secured Notes due 2023, of which $400 million aggregate principal amount was issued in 2018. (2019)
Radian Group
We represented the underwriters in Radian Group’s $450 million senior notes offering. (2019)
PartnerRe Ltd.
We represented the underwriters in PartnerRe’s $500 million senior notes offering. (2019)
MetLife, Inc.
We represented MetLife, Inc. in its public offerings of ¥151.7 billion senior notes. (2019)
Fidelity National Information Services
We represented FIS in its approximately US$8.2 billion (equivalent) multi-tranche senior notes offerings. (2019)
Marsh & McLennan Companies, Inc.
We represented the underwriters in Marsh & McLennan’s $5 billion multi-tranche debt offering, and €1.1 billion and $250 million senior notes offerings. (2019)
CURO Group Holdings Corp.
We represented CURO in its $690 million offering of 8.250% Senior Secured Notes due 2025. (2018)
Clovis Oncology, Inc.
We represented Clovis Oncology in its $300 million offering of convertible senior notes. (2018)
Tronox Limited
We represented Tronox Limited in an offering of $615 million 6.5% Senior Notes due 2026. (2018)
W. R. Berkley Corporation
We represented W. R. Berkley Corporation in its $175 million hybrid bond offering of subordinated debentures. (2018)
Marsh & McLennan Companies, Inc.
We represented the underwriters, led by joint book-running managers Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Barclays Capital Inc. and HSBC Securities (USA) Inc., in Marsh & McLennan Companies’ $600 million offering of senior notes. (2018)
Lennar Corporation
We represented Lennar as issuer in its offering of $300 million of 2.95% Senior Notes due 2020 and $900 million of 4.75% Senior Notes due 2027. (2017)
Tronox Limited
We represented Tronox Limited in an offering of $450 million 5.75% Senior Notes due 2025, together with the closing of new credit facilities. (2017)
RenaissanceRe
We represented RenaissanceRe Holdings Ltd.in the underwritten public offering by its subsidiary, RenaissanceRe Finance Inc., of $300 million aggregate principal amount of 3.450% Senior Notes due 2027. (2017)
Lennar Corporation
We represented Lennar as issuer in its offering of $650 million aggregate principal amount of its 4.50% Senior Notes due 2024. (2017)
iPayment
We represented iPayment in its $175 million 144A offering of 10.75% Senior Secured Second Lien Notes Due 2024. (2017)
Lennar Corporation
We represented Lennar as issuer in its offering of $600 million aggregate principal amount of its 4.125% Senior Notes due 2022. (2017)
MetLife, Inc.
We represented The Metropolitan Life Insurance Company in its issuance of $2 billion aggregate principal amount of senior secured notes. (2017)
Arch Capital Finance
We represented the underwriters in an aggregate $950 million public offering of senior notes by Arch Capital Group Ltd. (2016)
The Allstate Corporation
We represented The Allstate Corporation in connection with its offerings of $550 million 3.280% Senior Notes due 2026 and $700 million 4.200% Senior Notes due 2046. (2016)
LSB Industries, Inc.
We represented LSB Industries, Inc. in a successful consent solicitation to effect certain amendments to its 7.75% Senior Secured Notes due 2019 following the company’s $364 million sale of its climate control business. (2016)
Fidelity National Information Services, Inc.
We represented Fidelity National Information Services, Inc. (FIS) in its $2.5 billion public debt offering. (2016)
Teva Pharmaceutical Industries Ltd.
We represented Teva Pharmaceutical Industries Ltd. in its series of three multi-tranche, multi-market offerings of senior notes aggregating $20.4 billion to finance its pending acquisition of Actavis Generics, the worldwide generic pharmaceutical business of Allergan plc. (2016)
Joseph T. Ryerson & Son, Inc.
We represented Joseph T. Ryerson & Son, Inc., a Platinum Equity portfolio company, in its offering of $650 million aggregate principal amount of 11% Senior Secured Notes due 2022. (2016)
W. R. Berkley Corporation
We represented W. R. Berkley Corporation in its $290 million offering of subordinated debentures. (2016)
Radian Group Inc.
We represented the underwriters in Radian Group Inc.’s offering of $350 million senior notes. (2016)
The Hanover Insurance Group
We represented the lead book-running managers in The Hanover Insurance Group’s offering of $375 million senior notes. (2016)
Level 3 Communications, Inc.
We represented Level 3 in its offering of $775 million aggregate principal amount of its 5.25% Senior Notes due 2026. (2016)
Lennar Corporation
We represented Lennar as issuer in its offering of $500 million aggregate principal amount of its 4.750% Senior Notes due 2021. (2016)
W. R. Berkley Corporation
We represented W. R. Berkley Corporation in its $110 million offering of subordinated debentures. (2016)
WFS Global Holding
We represented Platinum Equity and WFS Global Holding in connection with the high yield notes offering to fund WFS’s acquisition of CAS and an amendment of an existing super senior secured revolving credit facility. (2016)
American Family Mutual Insurance Company
We represented American Family Mutual Insurance Company, S.I., in connection with the initial public offering of its affiliate Bowhead Specialty Holdings Inc. (2024)
Goldman Sachs & Co. LLC
We represented Goldman Sachs & Co. LLC, Citigroup, BofA Securities and the other underwriters in the $577 million initial public offering of Ibotta, Inc. (2024)
Hamilton Insurance Group
We represented Hamilton Insurance Group, Ltd. on its initial public offering. (2023)
Sites del Perú S.A.C.
We represented Sites del Perú S.A.C., a subsidiary of Sitios Latinoamérica, S.A.B. de C.V., in its inaugural offering of S/872 million ($235 million equivalent) in Senior Notes. (2023)
Vilmori & Cie/Limagrain
We represented Vilmorin & Cie, one of the world’s leading seed companies, in connection with the successful simplified public tender offer from Limagrain. (2023)
Fidelis Insurance Holdings Limited
We represented Fidelis Insurance Holdings Limited in connection with its initial public offering on the New York Stock Exchange. (2023)
ESH Acquisition Corp.
We represented ESH Acquisition Corp. in connection with its $115 million SPAC initial public offering. (2023)
Air France-KLM Group
We represented Air France-KLM Group in its €2.256 billion rights issue. (2022)
Exela Technologies, Inc.
We represented Exela Technologies, Inc. on its exchange of its Common Stock for 6.00% Series B Cumulative Convertible Perpetual Preferred Stock. (2022)
Post Oak Energy Capital/Earthstone Energy/Bighorn Permian Resources
We represented Post Oak Energy Capital, LP, as investor in the PIPE transaction as part of Earthstone Energy’s approximately $860 million acquisition of Bighorn Permian Resources’ assets. (2022)
Victory Capital
We represented Victory Capital in its $136 million secondary offering. (2021)
EG Acquisition Corp.
We represented EG Acquisition Corp. in its $225 million SPAC initial public offering. (2021)
Clovis Oncology, Inc.
We represented Clovis Oncology in its $125 million public offering of common stock. (2021)
Fidelis Insurance Holdings
We represented Fidelis Insurance Holdings in connection with its equity capital raise implemented by a rights offer to shareholders and a private placement with The Travelers Companies, Inc. (2021)
James River Group Holdings, Ltd.
Represented the underwriters in connection with James River Group Holding’s public offering of the company’s common shares, valued at $201,422,500. (2021)
Liberty Oilfield Services Inc.
We represented the selling stockholders, R/C Energy IV Direct Partnership, L.P. and R/C IV Liberty Holdings, L.P., funds affiliated with Riverstone Holdings, LLC, in their approximately $100 million sale of 8,700,000 shares of Class A common stock of Liberty Oilfield Services. (2021)
Genesis Park
We represented Genesis Park Acquisition Corp. in its $150 million SPAC initial public offering. (2020)
Sarissa Capital
We represented Sarissa Capital Acquisition Corp. in its $200 million SPAC initial public offering. (2020)
nCino, Inc.
We represented Insight Partners affiliates as selling stockholders in nCino’s $555 million secondary public offering of common stock (NASDAQ: NCNO). (2020)
AdaptHealth Corp.
We represented AdaptHealth Corp. in its $142 million common stock public offering of 9.2 million shares, and $350 million senior notes offering of 6.125% Senior Notes due 2028. (2020)
Tenable
We represented Insight Partners in its $294 million secondary offering of 9.2 million shares of common stock of Tenable Holdings (Nasdaq: TENB). (2020)
HealthEquity, Inc.
We represented HealthEquity in its $257.6 million offering of 4.6 million common shares. (2020)
Fidelis Insurance Holdings Limited
We advised Fidelis Insurance Holdings Limited on its $500 million capital raise implemented by a rights offer and a private placement. (2020)
RenaissanceRe Holdings Ltd.
We represented RenaissanceRe Holdings Ltd. in its registered public offering of 6,325,000 common shares (inclusive of the underwriters’ over-allotment option) and a concurrent private placement of 451,807 common shares, for total aggregate proceeds of approximately $1,095,546,015, after underwriting discounts and expenses. (2020)
Clovis Oncology, Inc.
We represented Clovis Oncology in its $90 million public offering of common stock. (2020)
RenaissanceRe Holdings Ltd.
We represented RenaissanceRe Holdings Ltd. In its secondary public offering of common shares by Tokio Marine & Nichido Fire Insurance Co. Ltd. (2020)
Liberty Oilfield Services Inc.
We represented the selling stockholders, R/C Energy IV Direct Partnership, L.P. and R/C IV Liberty Holdings, L.P., affiliates of Riverstone Holdings LLC, in their approximately $117 million sale of 8,000,000 shares of Class A common stock of Liberty Oilfield Services. (2019)
HealthEquity, Inc.
We represented HealthEquity in its approximately $412 million offering of 6.75 million common shares. (2019)
CURO Group Holdings Corp.
We represented CURO Group Holdings Corp., a technology-enabled highly diversified consumer finance company, and the selling stockholders in a secondary offering of common stock. (2018)
Clovis Oncology, Inc.
We represented Clovis Oncology in its $100 million public offering of common stock. (2018)
Arch Capital Group Ltd.
We represented the underwriters in Arch Capital Group’s approximately $502 million secondary public offering of common shares. (2018)
Liberty Oilfield Services Inc.
We represented issuer Liberty Oilfield Services and selling shareholder R/C Energy IV Direct Partnership in Liberty’s initial public offering. (2018)
CURO Group Holdings Corp.
We represented CURO Group Holdings Corp., a portfolio company of Friedman Fleischer & Lowe, in its IPO. (2017)
Essent Group Ltd.
We represented Essent Group in its $199.5 million public offering of 5,000,000 common shares. (2017)
Delivery Hero
We represented Insight Venture Partners in connection with Delivery Hero AG’s $1.1 Billion IPO. (2017)
Clovis Oncology, Inc.
We represented Clovis Oncology in its $235.75 million and $345 million underwritten public offerings of common stock. (2017)
Virtus Investment Partners, Inc.
We represented Virtus Investment Partners, Inc. in the public offerings of common stock and mandatory convertible preferred stock in connection with its pending acquisition of RidgeWorth Investments. (2017)
James River Group Holdings, Ltd.
We represented the underwriter in the secondary public offering of common shares by James River Group Holdings, Ltd. (2016)
Aspen Insurance Holdings
We represented Aspen Insurance Holdings in its public offering of $250 million of perpetual non-cumulative preference shares. (2016)
Arch Capital Group Ltd.
We represented the underwriters in the $436.5 million offering of depository shares by Arch Capital Group. (2016)
Ryerson Holding Corporation
We represented Ryerson Holding Corporation, a Platinum Equity portfolio company, in its $76.25 million public offering of common stock. (2016)
Bpifrance
We represented Bpifrance in connection with Vallourec’s €1 billion equity fundraising. (2016)